Frequently Asked Questions
This year the Scottish Drugs Forum #StopTheDeaths campaign highlights the role we all have in recognising and intervening when a person overdoses.
Overdose is not a rare occurrence and the difference between an overdose and a fatal overdose depends upon the immediate actions of people present at the time. You could save a life by recognising an overdose.
#StopTheDeaths images © SDF 2021
This nonprescription availability is an important milestone for states and territories, community organizations, harm reduction advocates, those working to prevent overdose, and people at risk for overdose. State policy has evolved since the initial FDA approval of naloxone in 1971 to reduce access barriers and allow distribution to laypersons for emergency response. More than 20 years ago, harm reduction organizations spearheaded efforts to distribute naloxone to laypersons, particularly people who use drugs and their friends and families. Significant research has demonstrated naloxone is safe and effective for layperson use even with brief training.
Turning Point is calling on the government to make naloxone routinely available to the police, paramedics and the general public, as only treatment and healthcare staff are currently able to distribute the drug.
Proposals to expand access to take-home naloxone supplies
The UK Government is consulting on proposed legislative amendments to widen access to take-home supplies of naloxone, without a prescription. Since the proposed changes to legislation would apply throughout the UK, they have made this consultation available in England, Wales, Scotland and Northern Ireland.